Anlon Healthcare Ratings Withdrawn By Brickwork Post Loan Facility Closure

Anlon Healthcare has had credit ratings withdrawn for its ₹24.50 crore bank loan facility and ₹10.36 crore in term loans by Brickwork Ratings. This action follows the closure of the specific financial facilities for which these loans were granted.

Rating Withdrawal Explained

Brickwork Ratings has officially withdrawn the credit ratings assigned to Anlon Healthcare Limited's bank loan facility and term loans.

The withdrawal covers a bank loan facility amounting to ₹24.50 crore and term loans totalling ₹10.36 crore.

The rating agency cited the closure of the specific facilities as the reason for this action.

Anlon Healthcare has obtained the necessary No Objection Certificates (NOCs) and closure letters from Punjab National Bank for these now-closed term loans.

Impact for Stakeholders

For investors and stakeholders, this means that any past credit rating reports from Brickwork Ratings concerning these specific facilities are no longer relevant or reflective of the company's current position regarding these obligations.

It indicates that the company has successfully settled or closed out these particular debt instruments with the lender.

Anlon Healthcare's Recent History

Anlon Healthcare, a pharmaceutical intermediates and API manufacturer, has been active in acquisitions, adding Bizotic Life Science (March 2026) and Apiqo Organics (January 2026) as subsidiaries.

The company also underwent an IPO in August-September 2025, with funds earmarked for expansion, debt repayment, and working capital.

The company's history includes periods where rating agencies flagged an 'Issuer Not Cooperating' status. For instance, Brickwork Ratings itself held this status from late 2023 to late 2025. CARE Ratings also previously flagged 'Issuer Not Cooperating' and noted delays in debt servicing around early 2026.

Current Debt Status

Shareholders should note that the specific credit risks associated with these closed loans are resolved.

This withdrawal highlights how credit ratings change based on the status of financial facilities.

Investors need to refer to updated financial health assessments and any new credit ratings if the company obtains them.

Ongoing Transparency Concerns

While the immediate credit risk tied to these specific closed loan facilities is resolved, the historical 'Issuer Not Cooperating' status from other rating agencies suggests potential ongoing concerns regarding information transparency.

Investors should monitor future financial disclosures and credit rating updates closely.

Industry Peers

Anlon Healthcare operates in the pharmaceutical API and intermediates sector. Its key peers include established companies with diversified portfolios such as Lupin Ltd., Dr. Reddy's Laboratories Ltd., and Cipla Ltd.

Looking Ahead

Monitor any new credit rating assignments for Anlon Healthcare's other or future facilities.

Keep an eye on the company's ongoing financial performance post-acquisitions and IPO fundraising.

Follow any updates regarding information provision to rating agencies.